Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Nukiwa

Showing results (121-130 of 130) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 130 results.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 9, 2013
Mycobacterium avium genotype is associated with the therapeutic response to lung infectionT Kikuchi, Y Kobashi, T Hirano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Prognostic value of nucleolar protein p120 in patients with resected lung adenocarcinomaG Sato, Y Saijo, B Uchiyama, et al.
Thorax|June 26, 2009
Association between mycobacterial genotypes and disease progression in Mycobacterium avium pulmonary infectionT Kikuchi, A Watanabe, K Gomi, et al.
The European Respiratory Journal|December 10, 2009
Pirfenidone in idiopathic pulmonary fibrosisH Taniguchi, M Ebina, Y Kondoh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2009
A phase II study of amrubicin combined with carboplatin for elderly patients with small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0405A Inoue, O Ishimoto, S Fukumoto, et al.
The European Respiratory Journal|January 29, 2011
Mycobacterial hypersensitivity pneumonitis requires TLR9-MyD88 in lung CD11b+ CD11c+ cellsH Daito, T Kikuchi, T Sakakibara, et al.
British Journal of Cancer|October 27, 2012
Carcinoembryonic antigen-related cell adhesion molecules as surrogate markers for EGFR inhibitor sensitivity in human lung adenocarcinomaM Kobayashi, Y Miki, M Ebina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2012
Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin-paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002)A Inoue, K Kobayashi, M Maemondo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 12, 2015
Randomized phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations: NEJ005/TCOG0902S Sugawara, S Oizumi, K Minato, et al.
American Journal of Respiratory and Critical Care Medicine|August 10, 2000
Serological diagnosis of idiopathic pulmonary alveolar proteinosisT Kitamura, K Uchida, N Tanaka, et al.
Pageof 13

Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 9, 2013
Mycobacterium avium genotype is associated with the therapeutic response to lung infectionT Kikuchi, Y Kobashi, T Hirano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Prognostic value of nucleolar protein p120 in patients with resected lung adenocarcinomaG Sato, Y Saijo, B Uchiyama, et al.
Thorax|June 26, 2009
Association between mycobacterial genotypes and disease progression in Mycobacterium avium pulmonary infectionT Kikuchi, A Watanabe, K Gomi, et al.
The European Respiratory Journal|December 10, 2009
Pirfenidone in idiopathic pulmonary fibrosisH Taniguchi, M Ebina, Y Kondoh, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2009
A phase II study of amrubicin combined with carboplatin for elderly patients with small-cell lung cancer: North Japan Lung Cancer Study Group Trial 0405A Inoue, O Ishimoto, S Fukumoto, et al.
The European Respiratory Journal|January 29, 2011
Mycobacterial hypersensitivity pneumonitis requires TLR9-MyD88 in lung CD11b+ CD11c+ cellsH Daito, T Kikuchi, T Sakakibara, et al.
British Journal of Cancer|October 27, 2012
Carcinoembryonic antigen-related cell adhesion molecules as surrogate markers for EGFR inhibitor sensitivity in human lung adenocarcinomaM Kobayashi, Y Miki, M Ebina, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 13, 2012
Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin-paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002)A Inoue, K Kobayashi, M Maemondo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 12, 2015
Randomized phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations: NEJ005/TCOG0902S Sugawara, S Oizumi, K Minato, et al.
American Journal of Respiratory and Critical Care Medicine|August 10, 2000
Serological diagnosis of idiopathic pulmonary alveolar proteinosisT Kitamura, K Uchida, N Tanaka, et al.
Pageof 13